Tekla World Healthcare Fund Stock Price, News & Analysis (NYSE:THW)

$13.50
-0.01 (-0.07 %)
(As of 09/23/2019 11:14 AM ET)
Today's Range
$13.46
Now: $13.50
$13.56
50-Day Range
$13.02
MA: $13.31
$13.55
52-Week Range
$10.80
Now: $13.50
$14.10
Volume2,313 shs
Average Volume121,046 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.11%
BetaN/A
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States.

Industry, Sector and Symbol

Industry Investment Trusts/Mutual Funds
Sub-IndustryN/A
SectorMiscellaneous
CUSIPN/A
CIKN/A
Phone617-772-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive THW News and Ratings via Email

Sign-up to receive the latest news and ratings for THW and its competitors with MarketBeat's FREE daily newsletter.


Tekla World Healthcare Fund (NYSE:THW) Frequently Asked Questions

What is Tekla World Healthcare Fund's stock symbol?

Tekla World Healthcare Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "THW."

How often does Tekla World Healthcare Fund pay dividends? What is the dividend yield for Tekla World Healthcare Fund?

Tekla World Healthcare Fund announced a -- dividend on Wednesday, September 11th. Investors of record on Friday, September 20th will be given a dividend of $0.1167 per share on Monday, September 30th. This represents a dividend yield of 10.4%. The ex-dividend date is Thursday, September 19th. View Tekla World Healthcare Fund's Dividend History.

Has Tekla World Healthcare Fund been receiving favorable news coverage?

Press coverage about THW stock has been trending somewhat negative on Monday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Tekla World Healthcare Fund earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Tekla World Healthcare Fund.

Who are some of Tekla World Healthcare Fund's key competitors?

What other stocks do shareholders of Tekla World Healthcare Fund own?

Who are Tekla World Healthcare Fund's key executives?

Tekla World Healthcare Fund's management team includes the folowing people:
  • Dr. Mark G. Charest M.B.A, Ph.D., Sr. VP of Research
  • Mr. Timothy L. Gasperoni, Sr. VP of Research
  • Mr. Peter J. Savitscus, Head of Trading
  • Mr. William R. Hite CFA, Sr. Analyst
  • Mr. Alan L. Kwan M.B.A, Ph.D., Sr. Analyst

Who are Tekla World Healthcare Fund's major shareholders?

Tekla World Healthcare Fund's stock is owned by many different of institutional and retail investors. Top institutional investors include Morgan Stanley (0.00%), Royal Bank of Canada (0.00%), Wells Fargo & Company MN (0.00%), Cohen & Steers Inc. (0.00%), LPL Financial LLC (0.00%) and Bank of America Corp DE (0.00%). Company insiders that own Tekla World Healthcare Fund stock include Daniel R Omstead and Thomas M Kent. View Institutional Ownership Trends for Tekla World Healthcare Fund.

Which major investors are selling Tekla World Healthcare Fund stock?

THW stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Sargent Investment Group LLC, AdvisorNet Financial Inc, BB&T Securities LLC, Royal Bank of Canada and Commonwealth Equity Services LLC. View Insider Buying and Selling for Tekla World Healthcare Fund.

Which major investors are buying Tekla World Healthcare Fund stock?

THW stock was bought by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Centaurus Financial Inc., Susquehanna International Group LLP, Sheaff Brock Investment Advisors LLC, LPL Financial LLC, Private Advisor Group LLC, Cohen & Steers Inc. and Wedbush Securities Inc.. Company insiders that have bought Tekla World Healthcare Fund stock in the last two years include Daniel R Omstead and Thomas M Kent. View Insider Buying and Selling for Tekla World Healthcare Fund.

How do I buy shares of Tekla World Healthcare Fund?

Shares of THW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tekla World Healthcare Fund's stock price today?

One share of THW stock can currently be purchased for approximately $13.50.

What is Tekla World Healthcare Fund's official website?

The official website for Tekla World Healthcare Fund is http://www.teklacap.com/.

How can I contact Tekla World Healthcare Fund?

The company can be reached via phone at 617-772-8500.


MarketBeat Community Rating for Tekla World Healthcare Fund (NYSE THW)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Tekla World Healthcare Fund and other stocks. Vote "Outperform" if you believe THW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THW will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/23/2019 by MarketBeat.com Staff

Featured Article: Dead Cat Bounce

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel